Jaber Hemmati

Jaber Hemmati

Auto-generated profile, based on publicly available information

Jaber Hemmati

Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
JHJaber Hemmati
Jaber Hemmati
MAMehdi Azizi
Mehdi Azizi
BABabak Asghari
Babak Asghari
MAMohammad Arabestani
Mohammad Arabestani
Multidrug‐resistant pathogens are one of the common causes of death in burn patients and have a high risk of nosocomial infections, especially pneumonia, urinary tract infections, and cellulitis. The role of prolonged hospitalization and empirical antibiotics administration in developing multidrug‐resistant pathogens is undeniable. In the early days of admitting burn patients, Gram‐positive bacteria were the dominant isolates with a more sensitive antibiotic pattern. However, the emergence of Gram‐negative bacteria that are more resistant later occurs. Trustworthy guideline administration in burn wards is one of the strategies to prevent multidrug‐resistant pathogens. Also, a multidisciplinary therapeutic approach is an effective way to avoid antibiotic resistance that involves infectious disease specialists, pharmacists, and burn surgeons. However, the emerging resistance to conventional antimicrobial approaches (such as systemic antibiotic exposure, traditional wound dressing, and topical antibiotic ointments) among burn patients has challenged the treatment of multidrug‐resistant infections, and using nanoparticles is a suitable alternative. In this review article, we will discuss different aspects of multidrug‐resistant pathogens in burn wounds, emphasizing the full role of these pathogens in burn wounds and discussing the application of nanotechnology in dealing with them. Also, some advances in various types of nanomaterials, including metallic nanoparticles, liposomes, hydrogels, carbon quantum dots, and solid lipid nanoparticles in burn wound healing, will be explained.

7 December 2023 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
JHJaber Hemmati
Jaber Hemmati
ZCZahra Chegini
Zahra Chegini
MAMohammad Arabestani
Mohammad Arabestani
Staphylococcus aureus, a prominent bacterial pathogen, presents formidable medical challenges owing to its rapid development of resistance. The emergence of multidrug resistant (MDR) S. aureus strains has become a pressing concern for healthcare systems, driving researchers to explore novel therapeutic strategies for managing infections associated with this pathogen. In this pursuit, niosomal-based platforms have emerged as promising candidates to effectively target S. aureus and fight conventional antimicrobial resistance. Niosomes comprise a bilayer membrane formed by nonionic surfactants, which can encapsulate both hydrophilic and hydrophobic drugs. These nanoparticles are known as vesicular delivery systems and have many advantages, such as low cost, less toxicity, and more flexibility and stability. Moreover, niosomes, being an effective drug delivery system, can directly interact with the bacterial cell envelope, thereby enhancing the pharmacokinetic activities of drugs at infected sites. A niosome-based delivery system can effectively treat S. aureus infections by destroying the biofilm community, increasing intracellular targeting, and enhancing the antibacterial activity. The main mechanisms of action of niosomes against resistant S. aureus strains involve the ability to resist enzymatic degradation, controlled release profile, and targeted drug delivery, which can provide an effective dosage of antimicrobial agents at the site of actions. In addition, niosomes have the potential to transfer wide-spectrum materials from different classes of antibiotics to nonantibiotic antimicrobial agents, such as natural compounds, antimicrobial peptides, and metallic nanoparticles. The combination of polymeric materials in the structure of a niosomal formulation could improve their bioavailability, loading capacity, and therapeutic efficacy for different applications. Furthermore, niosomes could find application in photodynamic therapy, offering a promising alternative to conventional treatments for eradicating drug-resistant S. aureus isolates. Finally, niosomal nanocarriers can be developed for delivering the drugs to desired sites by different routes of administration and could be considered a powerful strategy for overcoming the therapeutic obstacles caused by MDR S. aureus.

17 August 2024 in Molecular Biotechnology
Verified
Journal Article
Closed access
PDF file
MKMansoor Khaledi
Mansoor Khaledi
MKMehrdad Khatami
Mehrdad Khatami
JHJaber Hemmati
Jaber Hemmati
SBShahriar Bakhti
Shahriar Bakhti
SHSeyedeh Asal Hoseini
Seyedeh Asal Hoseini
HGHossein Ghahramanpour
Hossein Ghahramanpour

1 January 2025 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
JHJaber Hemmati
Jaber Hemmati
MCMohsen Chiani
Mohsen Chiani
BABabak Asghari
Babak Asghari
GRGhodratollah roshanaei
Ghodratollah roshanaei
SASara Sara Soleimani Asl
Sara Sara Soleimani Asl
MAMohammad Arabestani
Mohammad Arabestani
The clinical challenge of staphylococcal treatment is increasing globally, making it critical to find effective strategies to hinder the spread of resistant isolates, particularly methicillin‐resistant Staphylococcus aureus (MRSA). Niosomal drug delivery systems, known for their controlled release profiles and other advantageous features, can enhance the efficacy of antimicrobial ability of loaded agents. This study aims to propose a novel drug delivery system for combating staphylococcal resistance challenge through examining the antibacterial and antibiofilm properties of myrtenol‐loaded niosomal system against MRSA isolates. The niosomal formulation was prepared using the thin‐film hydration process, and its physicochemical characteristics were assessed through entrapment efficiency (EE %), in vitro release profile, field‐emission scanning electron microscopy (FE‐SEM), and dynamic light scattering (DLS). In addition, minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were measured and compared with free myrtenol to evaluate the anti‐MRSA activity of the formulated niosomal myrtenol. Furthermore, the effectiveness of niosome containing myrtenol against MRSA biofilms was investigated by examining biofilm minimum inhibitory and eradication concentrations (BMIC/BMEC). Additionally, the cytotoxicity of synthesized niosomes was assessed on the human foreskin fibroblast cell line (HFF). Results from FE‐SEM showed that myrtenol‐loaded niosomes were spherical with a diameter of 122.1 nm, while the hydrodynamic size reported from DLS was 130.8 nm. The surface charge and EE% of the prepared niosomal formulation were −53.6 mV and 62.90%, respectively. The niosomal myrtenol formulation demonstrated the increased antibacterial activity in comparison with free myrtenol formulation. Furthermore, myrtenol‐loaded niosomes reduced the biofilm formation potential in all MRSA isolates and effectively eradicated bacterial biofilms at equivalent concentrations of the non‐niosomal formulation. According to this study, niosomes exhibit high potential for drug delivery due to several favorable characteristics, including a sustained‐release profile, nontoxicity, small size, and high EE%. Niosomal delivery system presents a novel approach to combat bacterial infections, particularly those caused by MRSA isolates by enhancing antibacterial and antibiofilm activities of free myrtenol.

1 July 2024 in Scientific Journal of Kurdistan University of Medical Sciences
Verified
Journal Article
Closed access
RKRomina Kardan
Romina Kardan
MNMohsen Nazari
Mohsen Nazari
JHJaber Hemmati
Jaber Hemmati
AAAmjad Ahmadi
Amjad Ahmadi
MAMahtab Ashab
Mahtab Ashab

30 October 2019 in Journal of Shahrekord University of Medical Sciences
Verified
Journal Article
Open access
PDF file
JHJaber Hemmati
Jaber Hemmati
BZBehnam Zamanzad
Behnam Zamanzad
AGAbolfazl Gholipour
Abolfazl Gholipour
MRMohammad-Hessein Rezaei
Mohammad-Hessein Rezaei
Background and aims: Increasing the prevalence of nosocomial infections by multidrug resistant (MDR) Pseudomonas aeruginosa has severely challenged the choice of treatment and led to an increased mortality rate. Thus, this study investigated the frequency of class I and II integrons and its association with MDR. Materials and Methods: A total of 175 P. aeruginosa isolates were collected from Shahrekord teaching hospitals and Isfahan Shahid Chamran hospital during 12 months (from April 2008 to March 2009). Antibiotic susceptibility was determined by disc diffusion according to the Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing. The E-test strips of imipenem, ciprofloxacin, and amikacin were used to identify the minimum inhibitory concentration and MDR bacteria. Finally, the frequency of class I and II integrons genes was evaluated by using the polymerase chain reaction test. Results: The highest antibiotic resistance and the highest susceptibility belonged to meropenem (86.9%) and polymyxin B (96.0%) by disc diffusion, respectively. By the E-test, the highest and lowest resistance rates were reported for imipenem (97.2%) and ciprofloxacin (86.8%), respectively. The frequency of MDR strains was 82.3% as well. The frequency of class I and II integrons was 57.7% and 17.7% in all P. aeruginosa isolates, as well as 68.1%and 21.5% in the MDR isolates, respectively. There was also a significant correlation between I and II integrons and MDR. Conclusion: Overall, the resistance to different antibiotics and the frequency of MDR strains among the studied P. aeruginosa isolates were very high. There was also a significant correlation between integrons and multidrug resistance. Regarding the role of integrons in the transfer of drug-resistant genes and the development of MDR strains, the use of appropriate diet and accurate determination of the susceptibility pattern of P. aeruginosa isolates are considered necessary.